CVS Corporation Stock Quote

CVS Corporation Live Stock Price

CODE: CVS | SECTOR: Healthcare | INDUSTRY: Medical/Nursing Services

NYQ LIVE

Apr 25, 16:00
101.95
0.51 (0.50%)
VOLUME 2,322,774

Prev. Close

101.44

Open

101.00

Bid

100.69

Ask

103.64

1 Year Target Price

112.35

Day's Range

100.78 - 101.99
52 Week Range

81.37

Average Daily Volume

4,544,000

Market Capitalization

112.25B

P/E Ratio

22.03

Earnings/Share

4.63

Dividend Yield

1.68

Ask (Real-time)

N/A

Bid (Real-time)

N/A

Book Value

33.78

EPS Est. Current Year

5.82

EPS Est. Next Year

6.57

EPS Est. Next Quarter

1.35

Day's Low

100.78

Day's High

101.99

52-week Low

81.37

52-week High

113.65

50 Day Moving Avg.

101.69

200 Day Moving Avg.

98.06

Change from 200 Day Moving Avg.

3.89

%Change from 200 Day Moving Avg

+3.97%

Change from 50 Day Moving Avg.

0.25

% Change from 50 Day Moving Avg.

+0.25%

CVS Corporation News

  • These Data Show Why The Fed Doesn't Have To Hike Aggressively

    Consumer prices rose 0 4 in November and 2 2 from a year ago as expected lifted by a rise in energy prices the Labor Department reported on Wednesday ibd display video id 3020793 width 50 float left autostart true The 160 core consumer price index excluding food and...

  • CVS-Aetna Deal Leading a Wave of Change in Hospital Sector

    The mega merger of CVS Health Corp CVS with Aetna Inc AET announced recently has sent jitters across the hospital sector which is already suffering from low patient volumes soaring costs increasing bad debts and an uncertain regulatory climate among other issues Increasing...

  • Sanofi Wins FDA Approval for Biosimilar of Lilly's Humalog

    Sanofi SNY received FDA approval for Admelog its biosimilar version of Eli Lilly amp Company s LLY blockbuster rapid acting insulin Humalog insulin lispro Admelog is technically a follow on biologic version of Humalog which recorded sales of 2 08 billion in 2017 so far Admelog is...

  • Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 12/12/2017

    The following are today s upgrades for Validea s Growth Value Investor model based on the published strategy of James P O Shaughnessy This two strategy approach offers a large cap value model and a growth approach that looks for persistent earnings growth and strong relative strength...

  • How I Plan To Make 33 Percent On The CVS Merger

    The Affordable Care Act better known as Obamacare has completely rearranged the healthcare chessboard and left many wanting frustrated and confused especially now that its future has become less clear And I think it s safe to say that the real beneficiaries of the ACA have been...